BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32951474)

  • 1. Potential alteration of COVID-19 by beta-mercaptoethanol.
    Click RE
    Future Microbiol; 2020 Sep; 15():1313-1318. PubMed ID: 32951474
    [No Abstract]   [Full Text] [Related]  

  • 2. Herd immunity and COVID-19.
    Chen J; Ye L; Zhou MY; Cheng YR; Wang MW; Feng ZH
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4064-4065. PubMed ID: 32374011
    [No Abstract]   [Full Text] [Related]  

  • 3. Have deaths from COVID-19 in Europe plateaued due to herd immunity?
    Okell LC; Verity R; Watson OJ; Mishra S; Walker P; Whittaker C; Katzourakis A; Donnelly CA; Riley S; Ghani AC; Gandy A; Flaxman S; Ferguson NM; Bhatt S
    Lancet; 2020 Jun; 395(10241):e110-e111. PubMed ID: 32534627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Balavoine JF
    Rev Med Suisse; 2020 May; 16(695):1126. PubMed ID: 32462848
    [No Abstract]   [Full Text] [Related]  

  • 5. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?
    Laxminarayan R; John TJ
    Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793
    [No Abstract]   [Full Text] [Related]  

  • 6. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

  • 7. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    Kwok KO; Lai F; Wei WI; Wong SYS; Tang JWT
    J Infect; 2020 Jun; 80(6):e32-e33. PubMed ID: 32209383
    [No Abstract]   [Full Text] [Related]  

  • 8. Herd Immunity: Understanding COVID-19.
    Randolph HE; Barreiro LB
    Immunity; 2020 May; 52(5):737-741. PubMed ID: 32433946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.
    Demaria O; Carvelli J; Batista L; Thibult ML; Morel A; André P; Morel Y; Vély F; Vivier E
    Cell Mol Immunol; 2020 Sep; 17(9):995-997. PubMed ID: 32612152
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
    Papachristodoulou E; Kakoullis L; Parperis K; Panos G
    Pathog Dis; 2020 Apr; 78(3):. PubMed ID: 32510562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin and resistance to SARS coronavirus 2.
    Cunningham L; Simmonds P; Kimber I; Basketter DA; McFadden JP
    J Allergy Clin Immunol; 2020 Jul; 146(1):52-53. PubMed ID: 32422144
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating COVID-19 with Chloroquine.
    Huang M; Tang T; Pang P; Li M; Ma R; Lu J; Shu J; You Y; Chen B; Liang J; Hong Z; Chen H; Kong L; Qin D; Pei D; Xia J; Jiang S; Shan H
    J Mol Cell Biol; 2020 May; 12(4):322-325. PubMed ID: 32236562
    [No Abstract]   [Full Text] [Related]  

  • 14. The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients.
    Soni S; Dyck JRB
    Can J Cardiol; 2020 Oct; 36(10):1691.e3. PubMed ID: 32717278
    [No Abstract]   [Full Text] [Related]  

  • 15. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
    Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
    Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
    [No Abstract]   [Full Text] [Related]  

  • 17. Privileges and Immunity Certification During the COVID-19 Pandemic.
    Hall MA; Studdert DM
    JAMA; 2020 Jun; 323(22):2243-2244. PubMed ID: 32374358
    [No Abstract]   [Full Text] [Related]  

  • 18. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Transplantation and COVID-19.
    Merhi B; Gohh R
    R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.
    Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N
    Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.